Improve Research Reproducibility A Bio-protocol resource
Concise Method
tooltip

Additional Resources

JS Jonas Schulte-Schrepping
NR Nico Reusch
DP Daniela Paclik
KB Kevin Baßler
SS Stephan Schlickeiser
BZ Bowen Zhang
BK Benjamin Krämer
TK Tobias Krammer
SB Sophia Brumhard
LB Lorenzo Bonaguro
ED Elena De Domenico
DW Daniel Wendisch
MG Martin Grasshoff
TK Theodore S. Kapellos
MB Michael Beckstette
TP Tal Pecht
AS Adem Saglam
OD Oliver Dietrich
HM Henrik E. Mei
AS Axel R. Schulz
CC Claudia Conrad
DK Désirée Kunkel
EV Ehsan Vafadarnejad
CX Cheng-Jian Xu
AH Arik Horne
MH Miriam Herbert
AD Anna Drews
CT Charlotte Thibeault
MP Moritz Pfeiffer
SH Stefan Hippenstiel
AH Andreas Hocke
HM Holger Müller-Redetzky
KH Katrin-Moira Heim
FM Felix Machleidt
AU Alexander Uhrig
LJ Laure Bosquillon de Jarcy
LJ Linda Jürgens
MS Miriam Stegemann
CG Christoph R. Glösenkamp
HV Hans-Dieter Volk
CG Christine Goffinet
ML Markus Landthaler
EW Emanuel Wyler
PG Philipp Georg
MS Maria Schneider
CD Chantip Dang-Heine
NN Nick Neuwinger
KK Kai Kappert
RT Rudolf Tauber
VC Victor Corman
request Request a Protocol
ask Ask a question
Favorite

Part of the patients included in this study have been recruited within the clinical trial DRKS00021688, registered at the German registry for clinical studies (Kurth et al., 2020).

In addition to the deposition of the raw sequencing data on EGA, we provide an interactive platform for data inspection and analysis via FASTGenomics. The FASTGenomics platform (fastgenomics.org) provides processed count tables of the datasets generated in this study as well as key analytical results, such as UMAP coordinates and cluster identities, and the code written to analyze the respective data.

Copyright and License information:  ©2020 Elsevier Inc.
Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A